A genetic test could spare thousands of women with breast cancer from chemotherapy
A genetic test could spare thousands of women with breast cancer from chemotherapy, The Times reports.
Left 0 · Centre-left 0 · Centre 0 · Centre-right 1 · Right 0
Sources by leanFollow the moneyMore coverage
How each side framed it
Left-leaning outlets
No left-rated outlet in our sample covered it.
Centre outlets
No least-biased (centre) outlet in our sample covered it.
Right-leaning outlets
Right-rated outlets headline it: “Genetic test could spare thousands chemotherapy for breast cancer” (The Times).
Sources by lean
Balanced: the same number of articles from the left, the centre and the right (up to 3 each). The bar above still counts every rated outlet we found. Bias and factual ratings come from Media Bias/Fact Check. How we balance · All ratings.
Left 0
No left coverage found — blindspot
Centre 0
No centre coverage found — blindspot
Right 1
Showing 1 from right of 1 rated outlet (L 0 / C 0 / R 1). Capped at 1 because that is all we found on the thinnest side. More coverage
Follow the money
Not yet researched. We haven't yet looked at who gains or loses financially from this story, or who funds the main voices on each side. When we do, we check company filings, the Electoral Commission donations register, lobbying registers, annual reports, InfluenceMap and OpenSecrets, and we apply the same checks to every side. How we follow the money.
Who owns or funds the outlets covering this story (1 outlets)
| Outlet | Lean | Ownership & funding (MBFC) |
|---|---|---|
| The Times | Centre-right | The Times and Sunday Times is owned by News UK (News Corp UK & Ireland Limited), which American News Corp owns. The owner and Executive Chairman of News Corp are Rupert Murdoch. Revenue is derived from advertising and subscription fees. source |